Gaush Meditech Ltd. (HK:2407) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Gaush Meditech Ltd. has announced that its subsidiary, Gaush Teleon Ltd., has received a medical device registration certificate from China’s National Medical Products Administration for its new aspheric intraocular lens, which is designed to provide clear and stable vision for cataract patients. This development comes nearly two quarters ahead of schedule, marking a significant step in the company’s commitment to enriching its product line and highlighting its advanced R&D and production capabilities in the field of ophthalmology.
For further insights into HK:2407 stock, check out TipRanks’ Stock Analysis page.